Gilead Sciences (GILD) officer exercises 25,000 options and sells 28,000 shares.
Alpha Vantage · Stock Titan · · AI-summarised by FinFlash
Johanna Mercier, Chief Comm & Corp Aff Officer at Gilead Sciences (GILD), exercised options to acquire 25,000 common shares and subsequently sold 28,000 shares on November 16, 2026. These transactions, executed under a Rule 10b5-1 trading plan, involved sale prices ranging from Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.Understand the context